annual FCF:
$557.20M+$195.60M(+54.09%)Summary
- As of today (May 29, 2025), NBIX annual free cash flow is $557.20 million, with the most recent change of +$195.60 million (+54.09%) on December 31, 2024.
- During the last 3 years, NBIX annual FCF has risen by +$324.10 million (+139.04%).
- NBIX annual FCF is now at all-time high.
Performance
NBIX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$54.10M-$181.10M(-77.00%)Summary
- As of today (May 29, 2025), NBIX quarterly free cash flow is $54.10 million, with the most recent change of -$181.10 million (-77.00%) on March 31, 2025.
- Over the past year, NBIX quarterly FCF has dropped by -$65.00 million (-54.58%).
- NBIX quarterly FCF is now -77.00% below its all-time high of $235.20 million, reached on December 31, 2024.
Performance
NBIX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$492.20M-$65.00M(-11.67%)Summary
- As of today (May 29, 2025), NBIX TTM free cash flow is $492.20 million, with the most recent change of -$65.00 million (-11.67%) on March 31, 2025.
- Over the past year, NBIX TTM FCF has dropped by -$122.20 million (-19.89%).
- NBIX TTM FCF is now -19.89% below its all-time high of $614.40 million, reached on March 31, 2024.
Performance
NBIX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
NBIX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.1% | -54.6% | -19.9% |
| 3 y3 years | +139.0% | +212.5% | +381.6% |
| 5 y5 years | +321.2% | +58.2% | +74.0% |
NBIX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +139.0% | -77.0% | +140.5% | -19.9% | +381.6% |
| 5 y | 5-year | at high | +321.2% | -77.0% | +140.5% | -19.9% | +381.6% |
| alltime | all time | at high | +463.9% | -77.0% | +140.5% | -19.9% | +357.5% |
NBIX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $54.10M(-77.0%) | $492.20M(-11.7%) |
| Dec 2024 | $557.20M(+54.1%) | $235.20M(+56.9%) | $557.20M(+26.6%) |
| Sep 2024 | - | $149.90M(+182.8%) | $440.10M(-11.0%) |
| Jun 2024 | - | $53.00M(-55.5%) | $494.60M(-19.5%) |
| Mar 2024 | - | $119.10M(+0.8%) | $614.40M(+69.9%) |
| Dec 2023 | $361.60M(+12.0%) | $118.10M(-42.2%) | $361.60M(-6.0%) |
| Sep 2023 | - | $204.40M(+18.3%) | $384.70M(+37.0%) |
| Jun 2023 | - | $172.80M(-229.2%) | $280.80M(+18.3%) |
| Mar 2023 | - | -$133.70M(-194.7%) | $237.30M(-26.5%) |
| Dec 2022 | $322.90M(+38.5%) | $141.20M(+40.5%) | $322.90M(+82.4%) |
| Sep 2022 | - | $100.50M(-22.3%) | $177.00M(+33.5%) |
| Jun 2022 | - | $129.30M(-368.8%) | $132.60M(+29.7%) |
| Mar 2022 | - | -$48.10M(+923.4%) | $102.20M(-56.2%) |
| Dec 2021 | $233.10M(+7.1%) | -$4.70M(-108.4%) | $233.10M(-28.9%) |
| Sep 2021 | - | $56.10M(-43.3%) | $327.80M(+30.6%) |
| Jun 2021 | - | $98.90M(+19.4%) | $250.90M(-5.7%) |
| Mar 2021 | - | $82.80M(-8.0%) | $266.20M(+22.3%) |
| Dec 2020 | $217.60M(+64.5%) | $90.00M(-532.7%) | $217.60M(-2.1%) |
| Sep 2020 | - | -$20.80M(-118.2%) | $222.30M(-34.1%) |
| Jun 2020 | - | $114.20M(+233.9%) | $337.40M(+19.3%) |
| Mar 2020 | - | $34.20M(-63.9%) | $282.90M(+113.8%) |
| Dec 2019 | $132.30M(+72.7%) | $94.70M(+0.4%) | $132.30M(+61.2%) |
| Sep 2019 | - | $94.30M(+58.0%) | $82.09M(+85.1%) |
| Jun 2019 | - | $59.70M(-151.3%) | $44.35M(+9025.5%) |
| Mar 2019 | - | -$116.40M(-361.6%) | $486.00K(-99.4%) |
| Dec 2018 | $76.60M(-175.6%) | $44.49M(-21.3%) | $76.60M(+9.0%) |
| Sep 2018 | - | $56.56M(+257.1%) | $70.31M(+4202.7%) |
| Jun 2018 | - | $15.84M(-139.3%) | $1.63M(-102.6%) |
| Mar 2018 | - | -$40.29M(-205.5%) | -$62.84M(-38.0%) |
| Dec 2017 | -$101.27M(-8.2%) | $38.20M(-415.3%) | -$101.27M(-40.9%) |
| Sep 2017 | - | -$12.11M(-75.1%) | -$171.44M(-10.3%) |
| Jun 2017 | - | -$48.64M(-38.2%) | -$191.11M(+20.2%) |
| Mar 2017 | - | -$78.72M(+146.2%) | -$159.06M(+44.2%) |
| Dec 2016 | -$110.29M(+176.2%) | -$31.97M(+0.6%) | -$110.29M(+16.9%) |
| Sep 2016 | - | -$31.79M(+91.7%) | -$94.35M(+15.8%) |
| Jun 2016 | - | -$16.58M(-44.7%) | -$81.45M(+58.4%) |
| Mar 2016 | - | -$29.95M(+86.8%) | -$51.42M(+28.8%) |
| Dec 2015 | -$39.93M(-18.1%) | -$16.03M(-15.1%) | -$39.93M(+0.7%) |
| Sep 2015 | - | -$18.89M(-240.4%) | -$39.65M(+19.7%) |
| Jun 2015 | - | $13.45M(-172.9%) | -$33.13M(-42.1%) |
| Mar 2015 | - | -$18.46M(+17.2%) | -$57.19M(+17.3%) |
| Dec 2014 | -$48.75M(+61.7%) | -$15.75M(+27.3%) | -$48.75M(+10.6%) |
| Sep 2014 | - | -$12.37M(+16.5%) | -$44.07M(+3.7%) |
| Jun 2014 | - | -$10.61M(+5.9%) | -$42.52M(+1.2%) |
| Mar 2014 | - | -$10.02M(-9.5%) | -$42.03M(+39.4%) |
| Dec 2013 | -$30.15M(-16.9%) | -$11.07M(+2.4%) | -$30.15M(+7.6%) |
| Sep 2013 | - | -$10.81M(+6.8%) | -$28.03M(+8.5%) |
| Jun 2013 | - | -$10.12M(-646.4%) | -$25.83M(+13.3%) |
| Mar 2013 | - | $1.85M(-120.7%) | -$22.80M(-37.1%) |
| Dec 2012 | -$36.27M(+2404.5%) | -$8.95M(+4.0%) | -$36.27M(+122.0%) |
| Sep 2012 | - | -$8.61M(+21.3%) | -$16.33M(+196.2%) |
| Jun 2012 | - | -$7.10M(-38.9%) | -$5.51M(+23.7%) |
| Mar 2012 | - | -$11.61M(-205.7%) | -$4.46M(+207.7%) |
| Dec 2011 | -$1.45M(-102.9%) | $10.98M(+396.8%) | -$1.45M(-91.5%) |
| Sep 2011 | - | $2.21M(-136.6%) | -$16.97M(-6.4%) |
| Jun 2011 | - | -$6.04M(-29.8%) | -$18.12M(-134.1%) |
| Mar 2011 | - | -$8.60M(+89.4%) | $53.22M(+7.2%) |
| Dec 2010 | $49.63M | -$4.54M(-530.3%) | $49.63M(+23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $1.05M(-98.4%) | $40.20M(+43.4%) |
| Jun 2010 | - | $65.30M(-635.8%) | $28.03M(-155.1%) |
| Mar 2010 | - | -$12.19M(-12.8%) | -$50.90M(-4.2%) |
| Dec 2009 | -$53.13M(-29.6%) | -$13.97M(+25.8%) | -$53.13M(-4.4%) |
| Sep 2009 | - | -$11.11M(-18.5%) | -$55.59M(-6.1%) |
| Jun 2009 | - | -$13.63M(-5.4%) | -$59.20M(-3.7%) |
| Mar 2009 | - | -$14.41M(-12.3%) | -$61.45M(-18.6%) |
| Dec 2008 | -$75.49M(+25.9%) | -$16.43M(+11.6%) | -$75.49M(+19.0%) |
| Sep 2008 | - | -$14.73M(-7.3%) | -$63.42M(-10.1%) |
| Jun 2008 | - | -$15.88M(-44.2%) | -$70.51M(-4.1%) |
| Mar 2008 | - | -$28.45M(+552.6%) | -$73.49M(+22.6%) |
| Dec 2007 | -$59.96M(-41.5%) | -$4.36M(-80.0%) | -$59.96M(-17.3%) |
| Sep 2007 | - | -$21.82M(+15.7%) | -$72.48M(-14.4%) |
| Jun 2007 | - | -$18.86M(+26.4%) | -$84.69M(-12.0%) |
| Mar 2007 | - | -$14.92M(-11.6%) | -$96.29M(-6.0%) |
| Dec 2006 | -$102.44M(+169.4%) | -$16.89M(-50.4%) | -$102.44M(-8.1%) |
| Sep 2006 | - | -$34.02M(+11.7%) | -$111.44M(+232.8%) |
| Jun 2006 | - | -$30.46M(+44.6%) | -$33.48M(+5.9%) |
| Mar 2006 | - | -$21.07M(-18.6%) | -$31.61M(-16.9%) |
| Dec 2005 | -$38.03M(-75.2%) | -$25.88M(-158.9%) | -$38.03M(-18.7%) |
| Sep 2005 | - | $43.93M(-253.7%) | -$46.80M(-55.3%) |
| Jun 2005 | - | -$28.59M(+4.0%) | -$104.73M(-20.7%) |
| Mar 2005 | - | -$27.49M(-20.7%) | -$132.09M(-13.7%) |
| Dec 2004 | -$153.13M(+1050.4%) | -$34.65M(+147.4%) | -$153.13M(+11.3%) |
| Sep 2004 | - | -$14.01M(-75.0%) | -$137.56M(-2.3%) |
| Jun 2004 | - | -$55.94M(+15.2%) | -$140.83M(+14.1%) |
| Mar 2004 | - | -$48.54M(+154.4%) | -$123.44M(+827.3%) |
| Dec 2003 | -$13.31M(-84.3%) | -$19.08M(+10.4%) | -$13.31M(-53.0%) |
| Sep 2003 | - | -$17.27M(-55.2%) | -$28.33M(+3.8%) |
| Jun 2003 | - | -$38.54M(-162.6%) | -$27.28M(+157.5%) |
| Mar 2003 | - | $61.58M(-280.6%) | -$10.60M(-87.5%) |
| Dec 2002 | -$84.67M(+229.9%) | -$34.09M(+110.1%) | -$84.67M(+66.6%) |
| Sep 2002 | - | -$16.23M(-25.7%) | -$50.83M(+36.8%) |
| Jun 2002 | - | -$21.86M(+75.1%) | -$37.15M(+28.0%) |
| Mar 2002 | - | -$12.48M(+4796.1%) | -$29.03M(+13.1%) |
| Dec 2001 | -$25.66M(+21.7%) | -$255.00K(-90.0%) | -$25.66M(-19.8%) |
| Sep 2001 | - | -$2.55M(-81.4%) | -$31.98M(+0.3%) |
| Jun 2001 | - | -$13.74M(+50.8%) | -$31.88M(+15.1%) |
| Mar 2001 | - | -$9.12M(+38.7%) | -$27.69M(+31.3%) |
| Dec 2000 | -$21.09M(+70.0%) | -$6.57M(+168.4%) | -$21.09M(+68.5%) |
| Sep 2000 | - | -$2.45M(-74.4%) | -$12.51M(-15.2%) |
| Jun 2000 | - | -$9.55M(+280.0%) | -$14.76M(+43.1%) |
| Mar 2000 | - | -$2.51M(-225.7%) | -$10.31M(-16.8%) |
| Dec 1999 | -$12.40M(-13.9%) | $2.00M(-142.6%) | -$12.40M(-29.9%) |
| Sep 1999 | - | -$4.70M(-7.8%) | -$17.70M(+21.2%) |
| Jun 1999 | - | -$5.10M(+10.9%) | -$14.60M(+13.2%) |
| Mar 1999 | - | -$4.60M(+39.4%) | -$12.90M(-10.4%) |
| Dec 1998 | -$14.40M(-413.0%) | -$3.30M(+106.3%) | -$14.40M(+161.8%) |
| Sep 1998 | - | -$1.60M(-52.9%) | -$5.50M(-523.1%) |
| Jun 1998 | - | -$3.40M(-44.3%) | $1.30M(-138.2%) |
| Mar 1998 | - | -$6.10M(-208.9%) | -$3.40M(-173.9%) |
| Dec 1997 | $4.60M(+4.5%) | $5.60M(+7.7%) | $4.60M(-45.9%) |
| Sep 1997 | - | $5.20M(-164.2%) | $8.50M(+431.3%) |
| Jun 1997 | - | -$8.10M(-526.3%) | $1.60M(-82.6%) |
| Mar 1997 | - | $1.90M(-80.0%) | $9.20M(+109.1%) |
| Dec 1996 | $4.40M | $9.50M(-658.8%) | $4.40M(-186.3%) |
| Sep 1996 | - | -$1.70M(+240.0%) | -$5.10M(+50.0%) |
| Jun 1996 | - | -$500.00K(-82.8%) | -$3.40M(+17.2%) |
| Mar 1996 | - | -$2.90M | -$2.90M |
FAQ
- What is Neurocrine Biosciences annual free cash flow?
- What is the all time high annual FCF for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual FCF year-on-year change?
- What is Neurocrine Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly FCF year-on-year change?
- What is Neurocrine Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM FCF year-on-year change?
What is Neurocrine Biosciences annual free cash flow?
The current annual FCF of NBIX is $557.20M
What is the all time high annual FCF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual free cash flow is $557.20M
What is Neurocrine Biosciences annual FCF year-on-year change?
Over the past year, NBIX annual free cash flow has changed by +$195.60M (+54.09%)
What is Neurocrine Biosciences quarterly free cash flow?
The current quarterly FCF of NBIX is $54.10M
What is the all time high quarterly FCF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly free cash flow is $235.20M
What is Neurocrine Biosciences quarterly FCF year-on-year change?
Over the past year, NBIX quarterly free cash flow has changed by -$65.00M (-54.58%)
What is Neurocrine Biosciences TTM free cash flow?
The current TTM FCF of NBIX is $492.20M
What is the all time high TTM FCF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM free cash flow is $614.40M
What is Neurocrine Biosciences TTM FCF year-on-year change?
Over the past year, NBIX TTM free cash flow has changed by -$122.20M (-19.89%)